ATHN Has Strong Long Term Outlook
Symbols: ATHN
Tags: Deutsche Bank
Analysts at Deutsche Bank upgrade Athenahealth (NASDAQ: ATHN) from "hold" to "buy." The target price for ATHN has been raised from $40 to $51.
According to Deutsche Bank, the upgrade in rating is based on the removal of ATHN’s accounting overhang and a strong long term outlook.
ATHN’s shares moved up 2.62% to $40.75 at 2:49 pm. More Analyst Ratings here
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
We're Loving
